{"disease":{"id":"immunodeficiencies","name":"immunodeficiencies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00001281","title":"Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV","phase":"","overall_status":"RECRUITING","enrollment_count":2419,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04172467","title":"Quality Assurance of Secondary Immunodeficiencies (SID) in CLL/MM Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1086,"lead_sponsor_name":"AIO-Studien-gGmbH","has_results":true},{"nct_id":"NCT01953016","title":"Participation in a Research Registry for Immune Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":716,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT04852276","title":"COVID-19 Vaccination and Outcomes in Individuals With and Without Immune Deficiencies and Dysregulations","phase":"","overall_status":"COMPLETED","enrollment_count":308,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT07251179","title":"Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT06659588","title":"Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral Deficiency","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04636502","title":"Retrospective, Observational Chart Review Study Conducted in Poland to Document the Management and Clinical Outcome of CUVITRU and HYQVIA in Pediatric Participants (< 18 Years) With Primary Immunodeficiency (PID)","phase":"","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Shire","has_results":false},{"nct_id":"NCT01316549","title":"Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation","phase":"","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06954441","title":"V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.","has_results":false},{"nct_id":"NCT01380990","title":"Lentiviral (LV) Gene Therapy for Adenosine Deaminase (ADA) Deficiency","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Great Ormond Street Hospital for Children NHS Foundation Trust","has_results":true},{"nct_id":"NCT03609814","title":"Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03609827","title":"Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT02737384","title":"Hematopoietic Stem Cells Transplantation in Children With Combined Immunodeficiency (CID)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT00801931","title":"Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Columbia University","has_results":true},{"nct_id":"NCT03145545","title":"Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false}],"total":15},"guidelines":[],"source":"Drug Landscape verified database"}